Public ID: PID-9PJZ79
Preferential treatment of state-owned pharmaceutical firms in Thailand affecting UK exporters and investors
Trade barrier summary
Thai government procurement regulation allows price advantages for state-owned enterprises and the government pharmaceutical organisations (GPO) . Hospitals are also required to purchase medicines exclusively from the GPO. Overseas businesses do not have access to those benefits.
- Healthcare services
- Pharmaceuticals and biotechnology
22 July 2019
17 December 2020